Drug Shortage Report for POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE

Last updated on 2023-05-19 History
Report ID 175274
Drug Identification Number 00402206
Brand name POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE
Common or Proper name Potassium Chloride for Injection Concentrate
Company Name OMEGA LABORATORIES LIMITED
Market Status MARKETED
Active Ingredient(s) POTASSIUM CHLORIDE
Strength(s) 20mEq
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 10 x 20mL vial / fiole
ATC code B05XA
ATC description I.V. SOLUTION ADDITIVES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-11-29
Estimated end date 2023-05-19
Actual end date 2023-05-18
Shortage status Resolved
Updated date 2023-05-19
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 11177 HAMON
MONTREAL, QUEBEC
CANADA H3M 3E4
Company contact information info@omegalaboratory.com - 1-800-363-0584

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v14 2023-05-19 English Compare
v13 2023-05-18 French Compare
v12 2023-05-18 English Compare
v11 2023-03-24 French Compare
v10 2023-03-24 English Compare
v9 2022-12-09 French Compare
v8 2022-12-09 English Compare
v7 2022-11-30 English Compare
v6 2022-11-29 French Compare
v5 2022-11-29 English Compare
v4 2022-11-25 French Compare
v3 2022-11-25 English Compare
v2 2022-11-18 French Compare
v1 2022-11-18 English Compare

Showing 1 to 14 of 14